“A Phase 3, Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel Group Trial Investigating the Efficacy and Safety of Clobetasol Propionate Cream, 0.025% in the Treatment of Moderate to Severe Plaque Psoriasis for 14 Days”, J of Skin, vol. 5, no. 6, p. s33, Nov. 2021, doi: 10.25251/skin.5.supp.33.